Weitz & Luxenberg is currently taking cases of people who are experiencing complications or have had or need revision surgery because of Ethicon’s Physiomesh Flexible Composite Mesh or Atrium’s C-QUR surgical meshes.
Both C-QUR (pronounced “secure”) meshes and Physiomesh Flexible Composite Mesh are approved for hernia surgeries as well as other soft-tissue repairs. For C-QUR meshes, these other indications include traumatic or surgical wounds and chest-wall reconstruction.
Atrium C-QUR meshes have been linked to infections, discussed by the U.S. Food and Drug Administration (FDA) in a Warning Letter issued to Atrium in October, 2012. Ethicon Physiomesh Flexible Composite Mesh was voluntarily withdrawn worldwide for recurrence and reoperation rates higher than average occurring after laparoscopic ventral hernia repair.
Weitz & Luxenberg’s Defective Drugs and Medical Devices Practice Group Co-Chair Ellen Relkin says the firm is interested in talking to people in the U.S. who are experiencing pain or other complications, have had revision surgery – or have one scheduled – resulting from having had either Ethicon’s Physiomesh Flexible Composite Mesh or Atrium’s C-QUR meshes implanted.
Atrium C-QUR Meshes & Ethicon Physiomesh Flexible Composite Mesh Complications
Complications from Ethicon Physiomesh Flexible Composite Mesh or Atrium’s C-QUR meshes, for which many have required revision surgery, have also included:
- Severe or chronic pain
- Bowel obstructions
- Adhesion of the mesh to bowels
Both C-QUR meshes and Physiomesh Flexible Composite Mesh consist of polypropylene mesh with a film coating. C-QUR meshes are notable for using a coating derived, in part, from fish oil. Physiomesh Flexible Composite Mesh uses a polyglecaprone-25 compound.
W&L Can Help Patients Harmed by Surgical Mesh Products
If you have been harmed by Physiomesh Flexible Composite Mesh or C-QUR meshes and have suffered complications or need or have had revision surgery, a knowledgeable attorney can help you understand your options. You may be entitled to compensation for medical expenses, lost wages, and other costs.
Ms. Relkin, whose practice at Weitz & Luxenberg concentrates on medical device and pharmaceutical product liability, is leading the firm’s efforts in assisting clients who have been harmed by Physiomesh Flexible Composite Mesh or C-QUR meshes.
While past successes are no guarantee of future outcomes, our attorneys have decades of combined experience litigating defective drug and medical device cases. Among other achievements, Ms. Relkin played a lead role in the $1 billion global resolution reached in lawsuits over the recalled Stryker Rejuvenate and ABG II hip implants, paving the way for W&L clients to take part in the settlement along with injured plaintiffs represented by other law firms. She also played a critical role in securing a $2.5 billion global settlement for patients fitted with defective DePuy ASR hip implants.
Weitz & Luxenberg is ready to assist you, beginning with a free consultation. Contact us at (833) 544-0604 or by using the online form on this page to discuss your legal options.